Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk

Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning a bidding war ...

Pfizer wins $10B bidding war for obesity drug developer Metsera in major pharmaceutical acquisition

Pfizer has won a $10 billion deal to acquire obesity drug developer Metsera, securing foothold in lucrative weight-loss ...

Nationwide ADHD Medication Recall Update as FDA Sets Risk Level

FDA issues Class II recall for ADHD drug after quality concerns, with millions of prescriptions potentially impacted.

Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal

The announcement of the deal signaled an end to the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker ...

Amgen cholesterol drug cuts risk of first cardiac event by 25%

By Deena Beasley (Reuters) -Adding Amgen's cholesterol drug Repatha to standard therapy reduced major cardiovascular events ...

FDA opens investigation into ByHeart baby formula after 13 infants sickened with botulism

The FDA is warning against using certain ByHeart formula lots as they investigate over a dozen botulism cases across 10 ...

US FDA places clinical hold on Tenaya gene therapy trial for rare heart disease

Tenaya Therapeutics said on Friday the U.S. Food and Drug Administration has placed a clinical hold on its trial of an ...
Channel 3000

Long Island drug traffickers had enough fentanyl to kill all of Suffolk County, authorities say

Six men accused of trafficking catastrophic amounts of drugs to New York City and Long Island were arrested in a major ...